Overview

Synthetic vs Natural Estrogen in Combined Oral Contraception

Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
The main objective of the study is to compare the metabolic effects of natural estradiol and synthetic ethinylestradiol used in combined oral contraception in healthy women. A progestin-only preparation will be used in comparison. The main goal is to study the effects on glucose metabolism, coagulation and a markers of chronic inflammation (such as hs-CRP). Our hypothesis is that the natural estradiol preparation will influence blood glucose levels, markers of coagulation and chronic inflammation less than the ethinylestradiol preparation. The progestin-only preparation will not effect these parameters.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
Oulu University Hospital
Treatments:
Dienogest
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Ethinyl Estradiol
Nandrolone
Polyestradiol phosphate
Progestins